Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-024489
Filing Date
2021-06-17
Accepted
2021-06-17 18:18:25
Documents
2
Period of Report
2021-06-17

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 6286
2 EX-24 DOCUMENT attachment1.htm EX-24 3911
  Complete submission text file 0000899243-21-024489.txt   12360
Mailing Address 180 VARICK STREET NEW YORK NY 10014
Business Address 180 VARICK STREET NEW YORK NY 10014 (617) 699-5876
ATAI Life Sciences B.V. (Issuer) CIK: 0001840904 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address BLOCK A, APT.12 IL-PIAZZETTA, TOWER ROAD SLIEMA O1 SLM1605
Business Address BLOCK A, APT.12 IL-PIAZZETTA, TOWER ROAD SLIEMA O1 SLM1605 44 7557 251 563
Apeiron Investment Group Ltd. (Reporting) CIK: 0001845711 (see all company filings)

State of Incorp.: O1 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-40493 | Film No.: 211026263

Mailing Address C/O ATAI LIFE SCIENCES N.V. 180 VARICK STREET NEW YORK NY 10014
Business Address C/O ATAI LIFE SCIENCES N.V. 180 VARICK STREET NEW YORK NY 10014 929 207 2670
Presight II, LP (Reporting) CIK: 0001860536 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-40493 | Film No.: 211026262